Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H14NO4S2.C5H14NO |
| Molecular Weight | 524.652 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CCO.[O-]C(=O)C1=CC=C(C=C1)C2=CC=C(O2)\C=C3/SC(=S)N(CC4=CC=CC=C4)C3=O
InChI
InChIKey=GOWDQYRMBCOOJR-JHMJKTBASA-M
InChI=1S/C22H15NO4S2.C5H14NO/c24-20-19(29-22(28)23(20)13-14-4-2-1-3-5-14)12-17-10-11-18(27-17)15-6-8-16(9-7-15)21(25)26;1-6(2,3)4-5-7/h1-12H,13H2,(H,25,26);7H,4-5H2,1-3H3/q;+1/p-1/b19-12-;
| Molecular Formula | C5H13NO |
| Molecular Weight | 103.1628 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C22H15NO4S2 |
| Molecular Weight | 421.489 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2111362 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21900205 |
4.0 mM [EC50] |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
2869 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: FEMALE food status: FASTED |
|
1716 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1900 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg 1 times / day multiple, oral dose: 30 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
2594 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg single, oral dose: 100 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1800 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg 1 times / day multiple, oral dose: 100 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
15248 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: FEMALE food status: FASTED |
|
6950 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
8206 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg 1 times / day multiple, oral dose: 30 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
13962 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg single, oral dose: 100 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
9840 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg 1 times / day multiple, oral dose: 100 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
3.84 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: FEMALE food status: FASTED |
|
4.68 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg single, oral dose: 30 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
9.54 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
30 mg/kg 1 times / day multiple, oral dose: 30 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
3.95 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg single, oral dose: 100 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
3.48 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31270275/ |
100 mg/kg 1 times / day multiple, oral dose: 100 mg/kg route of administration: Oral experiment type: MULTIPLE co-administered: |
LEUKADHERIN-1 plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 04:39:32 GMT 2025
by
admin
on
Wed Apr 02 04:39:32 GMT 2025
|
| Record UNII |
THN3VQ67CA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
701219
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000005390
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
PRIMARY | |||
|
C165605
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
PRIMARY | |||
|
THN3VQ67CA
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
PRIMARY | |||
|
145711124
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
PRIMARY | |||
|
2055362-74-6
Created by
admin on Wed Apr 02 04:39:32 GMT 2025 , Edited by admin on Wed Apr 02 04:39:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|